ÑÏÈÑÎÊ ÏÎÑËÅÄÎÂÀÒÅËÜÍÎÑÒÅÉ

<110>  ONL Therapeutics, Inc.
       The Regents of the University of Michigan
 
<120>  ÏÅÏÒÈÄÍÛÅ ÊÎÌÏÎÇÈÖÈÈ È ÑÏÎÑÎÁÛ ÈÑÏÎËÜÇÎÂÀÍÈß

<130>  15428-9

<150>  US 62/155,711
<151>  2015-05-01

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  12
<212>  PRT
<213>  èñêóñòâåííàÿ ïîñëåäîâàòåëüíîñòü

<220>
<223>  èñêóñòâåííûé ïåïòèä; C-êîíöåâîé àìèä Met-12

<400>  1

His His Ile Tyr Leu Gly Ala Val Asn Tyr Ile Tyr 
1               5                   10          


<210>  2
<211>  12
<212>  PRT
<213>  èñêóñòâåííàÿ ïîñëåäîâàòåëüíîñòü

<220>
<223>  èñêóñòâåííûé ïåïòèä; íåáîëüøîé èíãèáèòîð ïåïòèäîâ, Met-12

<400>  2

His His Ile Tyr Leu Gly Ala Val Asn Tyr Ile Tyr 
1               5                   10